JPWO2020081920A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2020081920A5 JPWO2020081920A5 JP2021521144A JP2021521144A JPWO2020081920A5 JP WO2020081920 A5 JPWO2020081920 A5 JP WO2020081920A5 JP 2021521144 A JP2021521144 A JP 2021521144A JP 2021521144 A JP2021521144 A JP 2021521144A JP WO2020081920 A5 JPWO2020081920 A5 JP WO2020081920A5
- Authority
- JP
- Japan
- Prior art keywords
- wisp1
- pharmaceutical composition
- agent
- antibody
- inhibits
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024163238A JP2025011102A (ja) | 2018-10-19 | 2024-09-20 | 肝疾患を治療するための組成物および方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862747903P | 2018-10-19 | 2018-10-19 | |
| US62/747,903 | 2018-10-19 | ||
| PCT/US2019/056910 WO2020081920A1 (en) | 2018-10-19 | 2019-10-18 | Compositions and methods for treatment of liver disease |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024163238A Division JP2025011102A (ja) | 2018-10-19 | 2024-09-20 | 肝疾患を治療するための組成物および方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022512735A JP2022512735A (ja) | 2022-02-07 |
| JP2022512735A5 JP2022512735A5 (https=) | 2022-10-25 |
| JPWO2020081920A5 true JPWO2020081920A5 (https=) | 2022-10-25 |
Family
ID=70284106
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021521144A Withdrawn JP2022512735A (ja) | 2018-10-19 | 2019-10-18 | 肝疾患を治療するための組成物および方法 |
| JP2024163238A Pending JP2025011102A (ja) | 2018-10-19 | 2024-09-20 | 肝疾患を治療するための組成物および方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024163238A Pending JP2025011102A (ja) | 2018-10-19 | 2024-09-20 | 肝疾患を治療するための組成物および方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US20210388073A1 (https=) |
| EP (1) | EP3866852A4 (https=) |
| JP (2) | JP2022512735A (https=) |
| KR (1) | KR20210081366A (https=) |
| CN (2) | CN120305401A (https=) |
| AU (1) | AU2019361120A1 (https=) |
| CA (1) | CA3117098A1 (https=) |
| IL (1) | IL282251A (https=) |
| WO (1) | WO2020081920A1 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3154648A1 (en) | 2019-09-16 | 2021-03-25 | Opsidio, LLC | Anti-stem cell factor antibodies and methods of use thereof |
| US20220378843A1 (en) * | 2019-11-01 | 2022-12-01 | Figene, Llc | Fibroblast-based therapy for treatment of sclerosing cholangitis |
| CN117487010B (zh) * | 2022-08-02 | 2025-02-14 | 东莞市朋志生物科技有限公司 | 抗四碘甲状腺素抗体或其功能性片段、检测四碘甲状腺素的试剂和试剂盒 |
| AU2024232439A1 (en) * | 2023-03-03 | 2025-08-28 | Karydo Therapeutix, Inc. | Antibody or antigen-binding fragment of same |
| CN117045680B (zh) * | 2023-10-12 | 2023-12-08 | 北京国卫生物科技有限公司 | 促进肝脏再生的干细胞制剂及其制备方法 |
| WO2025179048A2 (en) * | 2024-02-20 | 2025-08-28 | Ecogenome Llc | Antibodies that bind dach1 and methods of use |
| CN119331100B (zh) * | 2024-10-16 | 2025-07-25 | 天津大学 | 特异性结合25-羟基维生素d的单克隆抗体及其应用 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2014770A3 (en) * | 1997-10-29 | 2009-02-18 | Genentech, Inc. | WNT-1 Iinduced secreted polypeptide WISP-2 |
| EP1177796B1 (en) * | 1999-04-27 | 2011-04-27 | Mitsubishi Tanabe Pharma Corporation | Medicament for prevention or therapeutic treatment of liver disease |
| JPWO2003014345A1 (ja) * | 2001-08-08 | 2004-11-25 | 味の素株式会社 | 肝星細胞活性化に関与する遺伝子パネル |
| CA2801066C (en) * | 2010-06-02 | 2021-02-09 | Alnylam Pharmaceuticals, Inc. | Compositions and methods directed to treating liver fibrosis |
| KR20160138580A (ko) * | 2014-04-15 | 2016-12-05 | 소렌토 쎄라퓨틱스, 인코포레이티드 | Wisp1에 결합하는 항원 결합 단백질 |
| AU2015360502A1 (en) * | 2014-12-10 | 2017-06-29 | Regents Of The University Of Minnesota | Genetically modified cells, tissues, and organs for treating disease |
| US11015196B2 (en) * | 2016-05-20 | 2021-05-25 | The General Hospital Corporation | Using microRNAs to control activation status of hepatic stellate cells and to prevent fibrosis in progressive liver diseases |
-
2019
- 2019-10-18 CN CN202411435476.8A patent/CN120305401A/zh active Pending
- 2019-10-18 EP EP19873989.8A patent/EP3866852A4/en active Pending
- 2019-10-18 WO PCT/US2019/056910 patent/WO2020081920A1/en not_active Ceased
- 2019-10-18 CN CN201980083971.8A patent/CN113271971A/zh active Pending
- 2019-10-18 CA CA3117098A patent/CA3117098A1/en active Pending
- 2019-10-18 AU AU2019361120A patent/AU2019361120A1/en active Pending
- 2019-10-18 US US17/286,011 patent/US20210388073A1/en not_active Abandoned
- 2019-10-18 JP JP2021521144A patent/JP2022512735A/ja not_active Withdrawn
- 2019-10-18 KR KR1020217014607A patent/KR20210081366A/ko active Pending
-
2021
- 2021-04-12 IL IL282251A patent/IL282251A/en unknown
-
2024
- 2024-09-04 US US18/824,691 patent/US20250223344A1/en active Pending
- 2024-09-20 JP JP2024163238A patent/JP2025011102A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6946399B2 (ja) | Ｃ／ＥＢＰα低分子活性化ＲＮＡ | |
| JP5248494B2 (ja) | タンパク質、それをコードする核酸および関連する使用方法 | |
| CN106834528B (zh) | 一种用于肝癌诊疗的生物标志物 | |
| US20120213737A1 (en) | Compositions and methods for therapeutic membrane repair | |
| Doroudgar et al. | S100A4 protects the myocardium against ischemic stress | |
| WO2018193902A1 (ja) | マイクロｒｎａによるｂ型肝炎ウイルスに対する抗ウイルス効果 | |
| JPWO2020081920A5 (https=) | ||
| Fu et al. | Delivering LINE1 antisense oligonucleotides via endothelial targeting extracellular vesicles to ameliorate myocardial infarction-induced cardiac senescence | |
| Yang et al. | Antiinflammatory properties of IL‐10 rescue small‐for‐size liver grafts | |
| WO2005042719A2 (en) | Methods for treating and preventing ischemia-reperfusion injury using rna interfering agents | |
| WO2025103391A1 (zh) | 用于抑制lpa的基因表达的sirna，含其的组合物及其用途 | |
| WO2024126765A1 (en) | Rnai-based therapies targeting claudin-1 for the treatment and prevention of fibrotic diseases | |
| Rajan et al. | Direct injection and expression in vivo of full-length cDNA of the cardiac isoform of alpha-2 macroglobulin induces cardiac hypertrophy in the rat heart | |
| US20230235403A1 (en) | Long non-coding rna as therapeutic target in cardiac disorders and cardiac regeneration | |
| EP3131569B1 (en) | Apoo for use in a method for treating cancer and various pathophysiological situations | |
| US20250163420A1 (en) | Promotion of Cardiomyocyte Proliferation and Regenerative Treatment of the Heart by Inhibition of microRNA-128 | |
| CN113186224B (zh) | 具有抑制乙肝病毒复制活性的microRNA-27a及其应用 | |
| JP7525578B2 (ja) | Ｃ／ＥＢＰα小分子活性化ＲＮＡ組成物 | |
| EP3873488B1 (en) | Pharmaceutical compositions for use in treating an hbv or hdv infection | |
| CN102355911A (zh) | 调节脂肪生成的Vgll3活性调节剂的用途 | |
| EP2320931A2 (en) | Compositions comprising mg29 nucleic acids, polypeptides and associated methods of use | |
| JP2025513018A (ja) | ＧＰＡＭを標的にするｓｉＲＮＡを用いて肝疾患を処置するための組成物および方法 | |
| Wang et al. | Robust loading and delivery of functional small RNAs via protein N-myristoylation-induced small extracellular vesicles | |
| WO2025007960A1 (zh) | 一种抑制AGT基因表达的RNAi剂及其应用 | |
| CN121568968A (zh) | 靶向乙型肝炎病毒基因的工程化基因转录阻抑工具及其用途 |